Acura Pharmaceuticals (ACUR) Stock Statistics & Valuation Metrics

Acura Pharmaceuticals has a market cap or net worth of $59.40K. The enterprise value is $161.40K.

Acura Pharmaceuticals has 66,001,785 shares outstanding. The number of shares has decreased by -2.65% in one year.

Acura Pharmaceuticals’s return on equity (ROE) is -4.94 and return on invested capital (ROIC) is -295.38%.

The current PE Ratio of Acura Pharmaceuticals is ―. Acura Pharmaceuticals’s PEG ratio is 0.50.

In the last 12 months, Acura Pharmaceuticals had revenue of 1.56M and earned -879.00K in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -742.00K and capital expenditures 0.00, giving a free cash flow of -742.00K billion.

Acura Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Acura Pharmaceuticals upcoming earnings date is ―, ―.

Acura Pharmaceuticals as a current ratio of 0.72, with Debt / Equity ratio of 112.36%

In the past 12 months, Acura Pharmaceuticals has paid 0.00 in taxes.

Acura Pharmaceuticals EV to EBITDA ratio is -37.54, with an EV/FCF ratio of -29.80.

Acura Pharmaceuticals has $65.00K in cash and marketable securities with $200.00K in debt, giving a net cash position of -$135.00K billion.

Gross margin is 94.24%, with operating margin of -77.67%, and net profit margin of -56.24%.

The average price target for Acura Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―